STOCK TITAN
  1. Home
  2. News
  3. CLBTW

Cellebrite DI Ltd. - CLBTW STOCK NEWS

Welcome to our dedicated news page for Cellebrite DI Ltd. (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite DI Ltd..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cellebrite DI Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cellebrite DI Ltd.'s position in the market.

News
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
Rhea-AI Summary
Cellebrite (CLBT) will announce its first-quarter 2024 financial results on May 23, 2024, followed by a live conference call and webcast to discuss the results and 2024 outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.59%
Tags
conferences earnings
-
News
Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership
Rhea-AI Summary
Cellebrite DI (CLBT) appoints David Gee as Chief Marketing Officer to enhance global marketing strategy and drive growth in digital investigations. Gee's vast experience in sales and marketing will help Cellebrite capitalize on expanding opportunities in the digital investigations market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
management
-
News
Cellebrite Files its 2023 Annual Report on Form 20-F
Rhea-AI Summary
Cellebrite DI (CLBT) files its Annual Report on Form 20-F for 2023 with the SEC, offering shareholders easy access to financial information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
News
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
Rhea-AI Summary
Cellebrite DI Ltd. introduces Cellebrite Endpoint Inspector SaaS, revolutionizing data access and analysis from remote devices with enhanced security. The solution offers streamlined data collection, real-time visibility, and automatic updates for faster acquisition of critical information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none
-
News
UPDATE – Cellebrite Announces 2024 Investor Day
Rhea-AI Summary
Cellebrite (CLBT) to host Investor Day in New York City on March 27, 2024, to showcase Digital Investigative solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
News
Cellebrite Announces 2024 Investor Day
Rhea-AI Summary
Cellebrite (CLBT) to host Investor Day in New York City on March 27, 2024, aiming to educate investors on its Digital Investigative solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
News
Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security
Rhea-AI Summary
Cellebrite DI Ltd. collaborates with Coalfire to secure FedRAMP authorization for its SaaS offerings, enhancing security and compliance for federal customers. The process, expected to be completed within twelve months, aims to streamline procurement, eliminate duplication, and ensure consistent security standards. Coalfire's expertise in guiding cloud service providers through the FedRAMP journey adds credibility to Cellebrite's commitment to delivering high-value, secure SaaS solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
-
News
Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase
Rhea-AI Summary
Cellebrite DI Ltd. (CLBT) announces the retirement of Haim Shani as a director, effective immediately. Mr. Shani, a distinguished member of the Board since 2019, had served as Chairman from August 2021 until August 2023. The company expresses gratitude for his contributions and looks forward to continuing its growth and market leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
none
-
News
Cellebrite Announces Fourth-Quarter 2023 Results
Rhea-AI Summary
Cellebrite (CLBT) reports record ARR of $315.7 million, up 27% year-over-year, with Q4 revenue of $93.0 million, up 26%. The company surpassed 'Rule of 45' with 27% ARR growth and 19% adjusted EBITDA margin in 2023, showcasing strong financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.95%
Tags
earnings
News
Cellebrite Revolutionizes Investigative Workflow with Groundbreaking End-to-End Platform to Solve More Cases Faster
Rhea-AI Summary
Cellebrite DI Ltd. (Nasdaq: CLBT) announced Case-to-Closure (C2C), an expanded end-to-end platform for examiners and investigators to solve cases faster and more defensibly to accelerate justice around the world. The platform offers multiple breakthrough technology solutions, including enhanced digital forensics software, workflow automation, data connection enhancements, and secure evidence storage. These innovations aim to reduce examination time, increase efficiency, and provide a complete view of investigation data, ultimately accelerating investigations and protecting more lives across global communities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none
Stock CLBTW logo
Cellebrite DI Ltd.

Nasdaq:CLBTW

CLBTW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

CLBTW Stock Data